QS Investors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

QS Investors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,560	Closed	-$602K	–	1601
2020 Q2	$602K	Sell	12,560 -1,100	-8%	-$85K	0.01%	856
2020 Q1	$861K	Buy	13,660 +1,100	+9%	+$98.9K	0.01%	705
2019 Q4	$1.49M	Hold	12,560	–	–	0.01%	672
2019 Q3	$834K	Sell	12,560 -300	-2%	-$20.1K	0.01%	820
2019 Q2	$1.02M	Buy	12,860 +11,360	+757%	+$1.02M	0.01%	787
2019 Q1	$168K	Buy	+1,500	New	+$164K	﹤0.01%	1268
2018 Q1	–	Sell	-500	Closed	-$29K	–	1994
2017 Q4	$29K	Hold	500	–	–	﹤0.01%	1523
2017 Q3	$29K	Hold	500	–	–	﹤0.01%	1566
2017 Q2	$61K	Hold	500	–	–	﹤0.01%	1474
2017 Q1	$57K	Buy	+500	New	+$58.4K	﹤0.01%	1485
2016 Q4	–	Sell	-2	Closed	-$1K	–	1966
2016 Q3	$1K	Hold	2	–	–	﹤0.01%	1814
2016 Q2	$1K	Sell	2 -2	-50%	-$292	﹤0.01%	1869
2016 Q1	$1K	Buy	4 +2	+100%	+$236	﹤0.01%	1841
2015 Q4	$1K	Buy	+2	New	+$339	﹤0.01%	1900

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

QS Investors's ICPT Position: Q3 2020 in Review

QS Investors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2020, closing a stake of 12,560 shares — an estimated $602K sold.

QS Investors first reported a position in ICPT in Q4 2015 and held it in 14 quarters. The position peaked at $1.49M in Q4 2019. 177 funds tracked by Wall St. Rank hold ICPT as of Q3 2020.

QS Investors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
QS Investors sold 12,560 Intercept Pharmaceuticals, Inc. shares in Q3 2020, an estimated $602K.
QS Investors first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2015 and held it in 14 quarters.
QS Investors's Intercept Pharmaceuticals, Inc. position peaked at $1.49M in Q4 2019.
177 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.